ACT-1004-1239
ACT-1004-1239 is a potent and selective oral CXCR7 antagonist with demonstrated immune-modulatory and promyelinating properties. It is a valuable research tool for investigating inflammatory demyelinating pathologies, supporting both in vitro mechanistic studies and in vivo disease model research.
Product Specifications
CAS Number
2178049-58-4
Product Name Alternative
ACT 1004 1239, ACT10041239, ACT-1004-1239
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
98.31% (May vary between batches)
Solubility
DMSO:5.25 mg/mL (10.05 mM)
Smiles
N (C (=O) [C@@H]1[C@@H] (NC (=O) C=2C=C (ON2) C3=C (F) C=C (F) C=C3) CCN (CC4CC4) C1) C5 (CC5) C=6N=CC=CN6
Molecular Formula
C27H28F2N6O3
Molecular Weight
522.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog